Dallas, TX, February 28, 2014 --(PR.com
)-- Over 800 patients, survivors, caregivers and healthcare professionals attended the free conference that focused on education on disease management and survivorship issues.
With the increase in cancer survivorship rates and the recent advances in Assisted Reproductive Technology, more and more cancer patients are making the decision to preserve their fertility. ReproTech’s goal is to educate oncology and other healthcare professionals on the importance of discussing Fertility Preservation with their patients at the time of diagnosis.
ReproTech, Ltd. has organized its Fertility Preservation Network to educate oncology professionals and caretakers, as well as provide much needed cryopreservation services. The network includes members in 34 states and the Caribbean. Additionally, the work of LiveSTRONG, including its Fertility Programs, has advanced the awareness of the need for Fertility Preservation among the oncology community.
About ReproTech, Ltd.
ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates cryostorage facilities in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at www.reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members may be found at www.fertilitypreservation.com.
About the Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world and provides free information and support services. More information may be found at www.lls.org.